Johnson & Johnson and Moderna are two healthcare companies that have successfully developed COVID-19 vaccines which are currently being distributed throughout the U.S.

More in category

3 Growth Stocks That Are Down Big: Is It Time to Add?
April 14, 2021The Motley Fool
3 Growth Stocks That Are Down Big: Is It Time to Add?
1 ETF I'm Going to Hold for Decades
April 14, 2021The Motley Fool
1 ETF I'm Going to Hold for Decades
2 Top Growth Stocks to Buy Right Now
April 14, 2021The Motley Fool
2 Top Growth Stocks to Buy Right Now
3 High-Growth Tech Stocks to Buy and Hold
April 14, 2021The Motley Fool
3 High-Growth Tech Stocks to Buy and Hold
Wall St set to open higher as JPMorgan, Goldman kick off bank earnings
April 14, 2021Reuters
Wall St set to open higher as JPMorgan, Goldman kick off bank earnings
U.S. vaccination pace picks up as officials say Johnson & Johnson pause won't slow rollout
April 14, 2021CNBC
U.S. vaccination pace picks up as officials say Johnson & Johnson pause won't slow rollout
EU moves up delivery of 50 million BioNTech-Pfizer vaccine doses
April 14, 2021MarketWatch
EU moves up delivery of 50 million BioNTech-Pfizer vaccine doses
Goldman Sachs stock rises after record profit and revenue beat by wide margins
April 14, 2021MarketWatch
Goldman Sachs stock rises after record profit and revenue beat by wide margins
Hundreds of companies and executives sign statement opposing voting restrictions in two-page ad in New York Times
April 14, 2021MarketWatch
Hundreds of companies and executives sign statement opposing voting restrictions in two-page ad in New York Times
This new ETF gets you access to the backbone of the crypto world
April 14, 2021MarketWatch
This new ETF gets you access to the backbone of the crypto world
U.S. stocks edge higher as investors parse Goldman Sachs, JPMorgan earnings
April 14, 2021MarketWatch
U.S. stocks edge higher as investors parse Goldman Sachs, JPMorgan earnings
J.P. Morgan net profit soars fivefold to $14.3 billion and revenue tops expectations, but stock slips
April 14, 2021MarketWatch
J.P. Morgan net profit soars fivefold to $14.3 billion and revenue tops expectations, but stock slips
Moderna and Novavax added to ‘mix and match’ COVID-19 vaccine trial
April 14, 2021MarketWatch
Moderna and Novavax added to ‘mix and match’ COVID-19 vaccine trial
This robot-run fund with a history of predicting Tesla price moves has just made these stock picks
April 14, 2021MarketWatch
This robot-run fund with a history of predicting Tesla price moves has just made these stock picks
Earnings season is starting. Why you might want to take a look at the weather, too.
April 14, 2021MarketWatch
Earnings season is starting. Why you might want to take a look at the weather, too.
Johnson & Johnson saga reveals critical strengths in the U.S. COVID-19 mass-vaccination strategy — and its weaknesses
April 13, 2021MarketWatch
Johnson & Johnson saga reveals critical strengths in the U.S. COVID-19 mass-vaccination strategy — and its weaknesses
Corporate earnings growth could hit a decade-high despite COVID-19 pandemic
April 13, 2021MarketWatch
Corporate earnings growth could hit a decade-high despite COVID-19 pandemic
The 24 most-hated stocks in the S&P 500, and why you should love them
April 13, 2021MarketWatch
The 24 most-hated stocks in the S&P 500, and why you should love them
Opinion: The madness of stock picking
April 13, 2021MarketWatch
Opinion: The madness of stock picking
Opinion: GameStop’s stock price is down 50% from the highs — and it’s still crazy
April 13, 2021MarketWatch
Opinion: GameStop’s stock price is down 50% from the highs — and it’s still crazy
Rare blood clots tied to J&J’s COVID-19 shot are similar to issues with AstraZeneca’s vaccine, FDA official says
April 13, 2021MarketWatch
Rare blood clots tied to J&J’s COVID-19 shot are similar to issues with AstraZeneca’s vaccine, FDA official says